12/5/2011 - BioPharm International Podcast (3of3): Sutro Biopharma's Trevor Hallam offers a glimpse into the future of drug design By: Trevor J. Hallam
BioPharm International Podcast (2of3): Sutro Biopharma's Trevor Hallam describes a future cGMP manufacturing facility By: Trevor J. Hallam
BioPharm International Podcast (1of3): Sutro Biopharma and Cell-Free Protein Expression Systems By: Trevor J. Hallam
James F. Zawada, Preparation and Testing of E. coli S30 In Vitro Transcription Translation Extracts Ribosome Display and Related Technologies Methods in Molecular Biology Volume 805, 2012, pp 31-41 Date: 20... read more →
SAN FRANCISCO, Oct. 17, 2011 - Sutro's Chief Scientific Officer, Trevor Hallam, Ph.D., to Highlight Company's Technology Platform for the Highly Specific Design and Manufacturing of Novel Protein Therapeutics Sutro Biopharma,... read more →
Study Shows Sutro Biopharma’s Biochemical Protein Synthesis Technology Enables Rapid Production and Scale-Up of Biopharmaceuticals Results Published in Biotechnology and Bioengineering Demonstrate that Cell-Free Production of a Biologically Active Human Cytokine Can be Scaled-up to Commercial Manufacturing Levels Study Featured in Journal’s Spotlight Section.
SAN FRANCISCO, May 19, 2011 - Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today announced that a study published in the July issue... read more →
James F. Zawada, Gang Yin, Alexander R. Steiner, Junhao Yang, Alpana Naresh, Sushmita M. Roy, Daniel S. Gold, Henry G. Heinsohn, Christopher J. Murray, Microscale to Manufacturing Scale-up of Cell-Free... read more →
PHARMACEUTICAL TECHNOLOGY Volume 35, pp. s8-s11 Industrializing Design, Development, and Manufacturing of Therapeutic Proteins By: Trevor J. Hallam, Christopher J. Murray.
BioCentury, The Bernstein Report on BioBusiness January 10, 2011 issue article, "Unnatural Selection" in the Tools & Techniques section by BioCentury Senior Editor, Ms. Susan Schaeffer. Read More
San Francisco, CA Jan. 7, 2011 - Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today announced that the company has entered into a... read more →